Navigation Links
Don't Lower Age for Cervical Cancer Test, Study Urges
Date:4/23/2009

Researchers say older women need screening as much as younger ones,,

THURSDAY, April 23 (HealthDay News) -- Cervical cancer screening should continue for women older than 50 -- even if they've had several negative test results -- because they have a similar level of risk as younger women, European researchers contend.

Previous studies have suggested there's little benefit in repeating smear tests in women 60 to 65 years old whose previous tests have been normal, and some experts have suggested that the age limit for the screening test should be lowered to 50.

But the new study, published online in BMJ, challenges that view.

Researchers analyzed the cervical cancer registry in The Netherlands and identified 219,000 women ages 45 to 54 and 445,000 women ages 30 to 44 who'd had three consecutive negative smear tests. During a follow-up period of 10 years, the incidence of cervical cancer was 41 per 100,000 among the younger women and 36 per 100,000 among the older women.

This indicates, the researchers said, that among women who've had regular screenings with normal results, age does not affect the risk of developing cervical cancer. Therefore, it would not be consistent to stop screening older women without relaxing the screening policy for younger women with similar screening histories, they said.

Bjorn Strander, director of cervical cancer screening at Sahlgren's University Hospital in Sweden, wrote in an accompanying editorial that new findings about invasive cancer in age groups above screening cutoff points need to be closely monitored, and experts should be ready to adjust screening ages as more information becomes available.

Modern computer technology makes it possible to issue personalized screening invitations to individuals, he noted. That would enable a shift of resources away from women who would not benefit from additional cervical cancer screening to those who woul
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. New Jersey Orthodontist Patrick T. Cuozzo Launches User-Friendly, State-of-the-Art New Website
2. The American Academy of Periodontology issues statement on periodontal treatment during pregnancy
3. Dental Implants Effective for Orthodontic Treatment
4. Dr. Ron Greenspan has Been Selected for the 2008 Best of San Diego Award in the Orthodontists Category by the U.S. Local Business Association
5. Orthodontists Offer Sweet Incentives for Tricky Halloween Treats
6. Ortho Organizers(R) Opens a Full-Service Orthodontic Laboratory
7. Researchers report periodontal disease independently predicts new onset diabetes
8. Align Technology Targets Mainstream Orthodontics Market With Invisalign Teen(TM)
9. Ron Greenspan DDS Creates Plan to Eliminate the Barriers to Orthodontic Treatment
10. Researchers uncover higher prevalence of periodontal disease in rheumatoid arthritis patients
11. Saving teeth by using periodontal ligament regeneration
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Don't Lower Age for Cervical Cancer Test, Study Urges
Don't Lower Age for Cervical Cancer Test, Study Urges
Breaking Medicine Technology:FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 2Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 3CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition 2CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition 35 Year Study Published in Diabetologia Demonstrated Long Term Safety of Lantus 28R 29 Compared to NPH 4685 15 Year Study Published in Diabetologia Demonstrated Long Term Safety of Lantus 28R 29 Compared to NPH 4685 25 Year Study Published in Diabetologia Demonstrated Long Term Safety of Lantus 28R 29 Compared to NPH 4685 35 Year Study Published in Diabetologia Demonstrated Long Term Safety of Lantus 28R 29 Compared to NPH 4685 45 Year Study Published in Diabetologia Demonstrated Long Term Safety of Lantus 28R 29 Compared to NPH 4685 5Health Integrated Hosts Industry Collaborative Focused on the Patient Centered Medical Home 28PCMH 29 50737 1Health Integrated Hosts Industry Collaborative Focused on the Patient Centered Medical Home 28PCMH 29 50737 2Health Integrated Hosts Industry Collaborative Focused on the Patient Centered Medical Home 28PCMH 29 50737 3NeoStem Inc Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs 50735 1NeoStem Inc Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs 50735 2NeoStem Inc Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs 50735 3NeoStem Inc Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs 50735 4